A novel ultrasensitive hybridization-based ELISA method for 2-methoxyphosphorothiolate microRNAs and its in vitro and in vivo application

Kenneth K. Chan, Zhongfa Liu, Zhiliang Xie, Ming Chiu, Hongyan Wang, Ping Chen, Sarah Dunkerson, Michael Chiu, Shujun Liu, Georgia Triantafillou, Ramiro Garzon, Carlo M. Croce, John C. Byrd, Natarajan Muthusamy, Guido Marcucci

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


MicroRNAs (miRNAs) are endogenous, small non-coding RNAs that bind to target mRNAs and regulate their expression. Recent evidence has indicated the involvement of miRNAs in human malignancies. It has been suggested that aberrantly down-regulated or up-regulated miRNAs may be replaced with synthetic miRNAs or antagomiRNAs, respectively, and restore normal cell functions. As therapeutic development requires analytical support, we developed and validated an ultrasensitive and selective assay for quantification of synthetic 2′-methoxyphosphorothiolate-miRNA in mouse plasma and cell lysate for the first time. The method is based on a hybridization-ligation fluorescence enzyme-linked immunosorbent assay and has provided a linear dynamic range of 10-1,000,000 pM for three synthetic miRNAs both singly and in a mixture. The intra- and inter-day coefficients of variation were <20% and the accuracy values nearly 100%. Using this assay, we performed pharmacokinetic studies of three synthetic miRNAs in mice treated with a single i.v. bolus dose of 7.5 mg kg-1. The 2-methoxyphosphorothiolate-miRNAs reached peak concentrations in the μM and nM ranges in plasma and bone marrow, respectively, and remained measurable at 24 h. These concentrations are in a range that shows biological activities. We conclude that this method provides a general and valuable tool for the pharmacologic study and clinical development of synthetic miRNAs.

Original languageEnglish (US)
Pages (from-to)556-568
Number of pages13
JournalAAPS Journal
Issue number4
StatePublished - Dec 2010
Externally publishedYes

Bibliographical note

Funding Information:
Funding This work was partially supported by a grant from Targeted Investment in Excellence (TIE) from the State of Ohio and by the National Institute of Health (Grant PO1 CA81534) and the National Cancer Institute (CA 102 031).


  • 2′-MeOPSmiRNAs
  • Pharmacokinetics
  • Quantification


Dive into the research topics of 'A novel ultrasensitive hybridization-based ELISA method for 2-methoxyphosphorothiolate microRNAs and its in vitro and in vivo application'. Together they form a unique fingerprint.

Cite this